Health Condition 1: L308- Other specified dermatitis
Conditions
Interventions
Intervention1: ANA: ANA done in all cases of clinically diagnosed polymorphous light eruption to rule out cutaneous lupus erythematosus
Intervention2: Nil: Nil
Intervention3: serum T3 and T4: serum T3
Sponsors
Dr Jayakrishna M S
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18-65 years diagnosed with polymorphous light eruption clinically Patients presenting with other skin diseases that are matched for age and sex
Exclusion criteria
Exclusion criteria: Patients who have been treated with topical steroids in the past 1 month Patients with other known photodermatoses or autoimmune diseases Pregnant or lactating women Patients not giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will measure the association between polymorphous light eruption and thyroid dysfunction, and the relevance and need for screening and evaluation of thyroid dysfunction in a patient presenting with polymorphous light eruption. eruptionTimepoint: Study will be conducted from June 2025 to December 2026 over a period of 1 year 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Jayakrishna M S
Department of Dermatology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
Outcome results
None listed